Latest Breaking News On - Zhi li - Page 2 : comparemela.com

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoJunshi biosciencesZhi liAustralia therapeutic goods administrationShanghai junshi biosciences co ltdUniversity cancer hospitalIr teamPr teamSingapore health sciences authorityInternational metastatic renal cell carcinoma database consortiumNational reimbursement drug listNational medical products administrationEuropean medicines agencyBiosciences announces approvalLine treatment

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer

Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Renal Cancer
koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoZhi liJunshi biosciencesJunshipharma junshi biosciencesPabout toripalimabShanghai junshi biosciences co ltdAustralia therapeutic goods administrationPr teamEuropean medicines agencyUniversity cancer hospitalSingapore health sciences authorityNational medical products administrationInternational metastatic renal cell carcinoma database consortiumNational reimbursement drug listIr team

Junshi Biosciences Announces 2023 Full Year Financial

SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading.

New zealandUnited kingdomSouth africaSan franciscoUnited statesRepublic ofZhi liJunshi bioscienceJunshi biosciencesTherapeutic goods administrationNational medical products administration of chinaIr teamShanghai junshi biosciences co ltdAustralian government department of healthRegulatory agencyPr team

Junshi Biosciences Announces 2023 Full Year Financial Results And Provides Corporate Updates

Junshi Biosciences Announces 2023 Full Year Financial Results And Provides Corporate Updates
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

New zealandSan franciscoUnited statesRepublic ofUnited kingdomSouth africaZhi liJunshi bioscienceJunshi biosciencesDrug administrationNational medical products administration of chinaTherapeutic goods administrationNational drug list for basic medical insuranceAustralian government department of healthPr teamShanghai junshi biosciences co ltd

Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates

SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading…

Republic ofNew yorkUnited statesNew zealandSan franciscoUnited kingdomSouth africaCarolyn rogersGabriel friedmanBarbara shecterJustin trudeauJoe oconnorJunshi biosciencesDavid rosenbergJunshi bioscienceZhi li